Tests of glycemia for the diagnosis of type 2 diabetes mellitus

Annals of Internal Medicine

Volumn 137, Issue 4, 2002, Pages 263-272

  Barr, R Graham ^a   Nathan, David M ^a   Meigs, James B ^a   Singer, Daniel E ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RELIABILITY; UNITED STATES;

EID: 0037143551     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-4-200208200-00011     Document Type: Article

References (112)

1. Mortality patterns - United States, 1997
2. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994
3. Economic consequences of diabetes mellitus in the U.S. in 1997
4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
5. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
6. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
7. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr
8. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
9. Trends in the prevalence and incidence of self-reported diabetes mellitus United States, 1980-1994
10. Weight change and diabetes incidence: Findings from a national cohort of US adults
11. Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: A population-based study
12. Is the incidence of diabetes increasing in all age-groups in The Netherlands? Results of the second study in the Dutch Sentinel Practice Network
13. Prevalence and incidence of NIDDM in Iceland: Evidence for stable incidence among males and females 1967-1991 - The Reykjavik Study
14. Incidence and prevalence of diabetes in Manitoba, 1986-1991
15. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study
16. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes
17. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria
18. Diabetes in older adults: Comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification
19. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan
20. Screening for diabetes in obese patients using the new diagnostic criteria [Letter
21. Impact of new diagnostic criteria for diabetes on different populations
22. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: Poor agreement in the Hoorn Study
23. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK
24. Intra- and interindividual variability of glucose tolerance in an elderly population
25. Reproducibility of the oral glucose tolerance test
26. Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart
27. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: The Hoorn Study
28. The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age
29. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors
30. Unterscheidung von gummi, dextrin, traubenzucker, und rohrzucker
31. Glucose tolerance and its value in diagnosis
32. The early recognition of diabetes mellitus
33. Criteria for and interpretation of normal glucose tolerance tests
34. The glucose tolerance test: A pitfall in the diagnosis of diabetes mellitus
35. 1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited
36. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes
37. Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
38. The Bedford Survey: Observations on retina and lens of subjects with impaired glucose tolerance and in controls with normal glucose tolerance
39. Epidemiologic studies of diabetes in the Pima Indians
40. Five-year follow-up report on the Birmingham diabetes survey of 1962. Report by the Birmingham Diabetes Survey Working Party
41. Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Report by the Birmingham Diabetes Survey Working Party
42. Hyperglycaemia and diabetes mellitus
43. Oral glucose tolerance tests and the diagnosis of diabetes: Results of a prospective study based on the Whitehall survey
44. Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes")
45. Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians
46. Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians
47. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry
48. Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study
49. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study
50. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study
51. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-Year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
52. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
53. Is there a glycemic threshold for mortality risk?
54. Misclassification of diabetic subjects may account for the increased vascular risk of impaired glucose tolerance: The Islington Diabetes Survey
55. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey
56. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: The Hoorn study
57. Is there a glycemic threshold for mortality risk?
58. Joint discussion: The International Collaborative Group
59. Diabetes mellitus among Navajo and Hopi indians: The lack of vascular complications
60. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
61. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
62. Lag times between blood sampling, spinning and plasma glucose estimation
63. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: The Verona Diabetes Study
64. From diagnosis and classification to complications and therapy. DCCT. Part II? Diabetes Control and Complications Trial
65. American Diabetes Association: Tests of glycemia in diabetes
66. Isn't it time to retire the oral glucose tolerance test for diabetes screening and diagnosis?
67. Why use the oral glucose tolerance test?
68. Diagnosing diabetes mellitus - Do we need new criteria?
69. Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria
70. Clinical application of the glycosylated hemoglobin
71. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
72. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes
73. The clinical information value of the glycosylated hemoglobin assay
74. 1c determination methods in patients with hemoglobinopathies
75. Evaluation of GHb assays in France by national quality control surveys
76. 1c) testing
77. Intraindividual variation of glycohemoglobin: Implications for interpretation and analytical goals
78. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring
79. Comparison of glycosylated hemoglobin with the oral glucose tolerance test. A study in subjects with normoglycemia, glucose intolerance and non-insulin-dependent diabetes mellitus
80. The glycohaemoglobin assay as a screening test for diabetes mellitus: The Islington Diabetes Survey
81. Glycosylated haemoglobins in the diagnosis of diabetes mellitus and for the assessment of chronic hyperglycaemia
82. Glycohemoglobin. Its use in the follow-up of diabetes and diagnosis of glucose intolerance
83. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy
84. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial
85. Standards of medical care for patients with diabetes mellitus
86. High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance
87. A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels
88. Postprandial blood glucose
89. Diabetic retinopathy
90. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
91. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
92. Management of dyslipidemia in adults with diabetes
93. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
94. Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria
95. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality
96. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
97. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus
98. Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors
99. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
100. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
101. Effects of changing diagnostic criteria on the risk of developing diabetes
102. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
103. The ten-year follow-up of the Bedford survey (1962-1972): Glucose tolerance and diabetes
104. Development of diabetes in Japanese subjects with impaired glucose tolerance: A seven year follow-up study
105. The natural history of impaired glucose tolerance in the Micronesian population of Nauru: A six-year follow-up study
106. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies